{
    "title": "Sanofi lifts profit outlook as Dupixent sales surge 43%",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11056895/Sanofi-lifts-profit-outlook-Dupixent-sales-surge-43.html",
    "date": "2022-07-28",
    "keywords": [
        "group",
        "dupixent",
        "business",
        "burger",
        "healthcare",
        "growth",
        "sanofi",
        "analyst",
        "revenue",
        "covid19",
        "july",
        "outlook",
        "drug",
        "statement",
        "thursday",
        "share",
        "effect",
        "currency",
        "percentage",
        "secondquarter",
        "income",
        "interest",
        "tax",
        "estimate",
        "companys",
        "website",
        "march",
        "regeneron",
        "target",
        "treatment",
        "quarter",
        "consensus",
        "dermatitis",
        "asthma",
        "consumer",
        "unit",
        "maker",
        "overthecounter",
        "europe",
        "latin",
        "america",
        "upswing",
        "finance",
        "jeanbaptiste",
        "chatillon",
        "boehringer",
        "ingelheim",
        "progress",
        "plan",
        "standalone",
        "cfo",
        "listing",
        "month",
        "market",
        "value",
        "gsk",
        "pfizer",
        "development",
        "partner",
        "vaccine",
        "candidate",
        "beta",
        "opportunity",
        "beginning",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}